NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / India News / Bharat Biotech has refused additional COVAXIN doses to Delhi: Sisodia
    Next Article
    Bharat Biotech has refused additional COVAXIN doses to Delhi: Sisodia
    Bharat Biotech has reportedly refused additional COVAXIN doses to Delhi

    Bharat Biotech has refused additional COVAXIN doses to Delhi: Sisodia

    By Sneha Das
    (PTI desk)
    Edited by Anamica Singh
    May 12, 2021
    04:35 pm

    What's the story

    Deputy Chief Minister Manish Sisodia on Wednesday said that Hyderabad-based Bharat Biotech has informed the Delhi government that it cannot provide "additional" doses of COVAXIN to the national capital.

    "The stock of COVAXIN in Delhi has finished and as a result around 100 vaccination centers set up in 17 schools have been closed," he further said.

    Quote

    Central government is controlling the supply of the vaccine: Sisodia

    "The COVAXIN manufacturer has in a letter said that it cannot provide Delhi government vaccines due to unavailability, under the instruction of concerned government official. It means that the central government is controlling the supply of the vaccine," Sisodia said.

    Vaccines

    Government should approve vaccines available in international market: Sisodia

    The deputy chief minister said the Centre should stop the export of vaccines and share the vaccine formulae of the two manufacturers in the country with other companies for mass-scale production.

    He also requested the Union government to approve COVID-19 vaccines available in the international market for use in India, and direct states to vaccinate everyone within three months.

    Company

    Disheartening to see some states complaining about company: Bharat Biotech

    Meanwhile, a top company official said on Wednesday that it is quite disheartening to listen to some states complain about Bharat Biotech's intentions regarding the supply of the vaccine.

    In a tweet, Joint Managing Director Suchitra Ella said the company has already dispatched COVAXIN lots to 18 states on May 10. She also informed that 50 employees are off work due to COVID-19.

    Information

    Hyderabad-based firm is supplying COVAXIN to 18 states

    The Hyderabad-based firm is supplying COVAXIN to 18 states, including Andhra Pradesh, Haryana, Odisha, Assam, Jammu & Kashmir, Tamil Nadu, Bihar, Jharkhand, and Delhi. Other states are Chhattisgarh, Karnataka, Telangana, Tripura, Madhya Pradesh, Uttar Pradesh, Gujarat, Maharashtra, and West Bengal.

    COVAXIN

    COVAXIN phase 2/3 trials for 2-18-year-olds recommended by expert panel

    Meanwhile, in a bid to extend the country's vaccination drive to include people below 18 years, an expert panel on Tuesday recommended COVAXIN for phase 2/3 clinical trials on children and adolescents aged two to 18 years.

    The trials would be conducted on 525 subjects across numerous sites, including AIIMS-Delhi, AIIMS-Patna, and Meditrina Institute of Medical Sciences, Nagpur, among others.

    COVID-19 third wave

    Possible third wave likely to be dangerous for children: Experts

    Notably, this development comes amid reports that the possible third COVID-19 wave in India is likely to be dangerous for children.

    Experts say that the first wave affected older people, and in the ongoing second wave, youngsters are getting more infected, while the third wave could see more infections in children.

    Hence, ensuring vaccination of children is crucial to prepare for the third wave.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    Manish Sisodia
    COVAXIN

    Latest

    IPL 2025, Faf du Plessis leads DC versus PBKS: Details Faf du Plessis
    Israeli soldiers used human shields in Gaza, report claims Hamas
    Woman leaves son as collateral for loan; finds him dead Andhra Pradesh
    BJP could win majority in Karnataka today: Survey report Bharatiya Janata Party (BJP)

    Manish Sisodia

    #SignatureBridge: 14-years in making, Delhi finally gets an engineering marvel Aam Aadmi Party (AAP)
    #SignatureBridge: BJP and AAP supporters fight at inauguration Aam Aadmi Party (AAP)
    TM Krishna's canceled Delhi-concert rescheduled, after AAP steps in Arvind Kejriwal
    Kejriwal worried about women-safety but invited Kailash Kher to perform Arvind Kejriwal

    COVAXIN

    Three lakh healthcare workers will be inoculated on Day 1 Vaccine
    PM Modi to launch India's coronavirus vaccination drive Narendra Modi
    Before vaccination drive, Centre explains dos and don'ts to states Narendra Modi
    Delhi: 81 sites identified for COVID-19 vaccination Vaccine
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025